GILEAD SCIENCES, INC. bought XLO
February 13, 2026 · Form 4 insider transaction
GILEAD SCIENCES, INC. bought 3,739,000 shares of Xilio Therapeutics, Inc. at $0.53 per share, a transaction worth $2.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,739,000
Price
$0.53
Total value
$2.00M
InsiderGILEAD SCIENCES, INC.
Role—
SecurityPrefunded Warrants (right to buy)
Transaction codeP: Open-market purchase
Transaction dateFebruary 13, 2026
Filing dateFebruary 17, 2026
Shares owned after40,384,266
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Prefunded Warrants are exercisable at any time on or after the date of issuance and have no expiration date. A holder of Prefunded Warrants may not exercise such warrants if, after giving effect to such exercise, the holder and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the outstanding shares of Common Stock of the Issuer.